BioDiscovery, Inc. announced today an agreement with Be Creative Lab (Beijing) Co. Ltd., Beijing, China where Be Creative will be the exclusive reseller and distributor of BioDiscovery products in China. The two companies inked the deal at the recent 2017 Clinical Application Conference in Beijing where Be Creative debuted BioDiscovery’s NxClinical 4.0 software system, a […]

El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic data analysis software solutions announced today an agreement with Be Creative Lab (Beijing) Co. Ltd., Beijing, China where Be Creative will be the exclusive reseller and distributor of BioDiscovery products in China. The two companies inked the deal at the recent 2017 Clinical Application Conference […]

SALT LAKE CITY — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA has validated […]

First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and […]

Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies SALT LAKE CITY—-This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomicswill announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to clinical labs. The offering enables therapy matching for cancer […]

CAMBRIDGE, England Global Gene Corp today announced a collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), Department of Radiation Oncology, to develop a better understanding of rare cancers in South Asian and Indian populations. The collaboration with the OSUCCC – James […]

Increased Use of Physiologically-based Pharmacokinetic (PBPK) Modeling and Simulation (M&S)  is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of […]

PORTLAND, OR and CAMBRIDGE, MA— MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System.  MolecularMD has completed validation of the MSI Analysis System for the analysis of multiple tumor types and is now offering the technology as part of a broader portfolio of diagnostic and clinical […]

HOUSTON — Genialis, Inc., a leading provider of cloud software for the visual exploration of next generation sequencing data, recently closed a $2.3M Seed round. The financing will accelerate the team’s expansion in the U.S. and commercialization of Genialis Platform. Redalpine Venture Capital in Zurich and First Star Venture Capital in Boston co-led the round, joined by Slovenian firm Pikas d.o.o. Several expert […]